Join leading optometrists and ophthalmologists for two days of high-impact education, real-world clinical insights, and meaningful collaboration at EyeCon 2026, taking place September 26–27 at the Margaritaville Hollywood Beach Resort in Hollywood, Florida. Designed for today’s eye care professionals, EyeCon...
Free CE/CME
For patients with sickle cell disease (SCD), the transition from pediatric to adult care is a high-risk period that is often marked by gaps in care and worsening outcomes. This educational program brings together experienced hematologists to share data, clinical...
Free CE/CME
This Expert Illustrations & Commentaries™ is a video-based program in which 2 experts discuss key clinical aspects of paroxysmal nocturnal hemoglobinuria (PNH). In this activity, the faculty focus on pathophysiology and therapeutic strategies for the management of PNH. Their discussion...
This Burst CME is a video-based program in which an expert faculty presents and discusses the latest in the management of chronic kidney disease (CKD) and fluid overload. The content focuses on the guidelines for the treatment of CKD, the...
Free CE/CME
Cardiometabolic disorders are a significant source of morbidity and mortality in psoriatic disease. The presence of traditional cardiovascular (CV) risk factors, such as hypercholesterolemia, metabolic syndrome, and obesity, contributes to the elevated risk of CV disease in patients with psoriasis....
Macular telangiectasia type 2 (MacTel) is a rare, progressive retinal disease characterized by neurodegenerative changes, localized retinal degeneration, and alterations in the retinal vasculature. It usually presents bilaterally and leads to gradual central vision loss, and its early signs and...
Free CE/CME
Much progress has been made in managing and treating atopic dermatitis (AD) within the past few years. This 3-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Since its...
Free CE/CME
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis globally and an important cause of chronic kidney disease and kidney failure in young adults. As understanding of its complex autoimmune and inflammatory mechanisms deepens, new opportunities are emerging to...
Free CE/CME
Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...
Nearly half the population older than 60 years has more than 1.0 diopter of keratometric astigmatism. With the emergence of more advanced intraocular lenses (IOLs) and surgical technologies, corneal astigmatism management has become an important treatment goal in modern cataract...